Startup

Abionic

Description

Abionic, based in the Biopole life sciences campus in Lausanne, Switzerland, is a pioneering company developing in vitro diagnostic solutions using proprietary nanofluidic technology. Their innovative abioSCOPE(r) platform enables healthcare professionals to conduct ultra-rapid panel tests at the point of care, analyzing up to 14 parameters simultaneously with just one drop of blood in about 5 minutes. With a primary focus on fighting sepsis, Abionic is an active member of the Global Sepsis Alliance, striving to save lives by providing cost-effective, laboratory-quality results with easy handling for non-specialists.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.